Cite
Towards Neuroimmunotherapy for Cancer: the Neurotransmitters Glutamate, Dopamine and GnRH-II augment substantially the ability of T cells of few Head and Neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains
MLA
Saussez, Sven, et al. “Towards Neuroimmunotherapy for Cancer: The Neurotransmitters Glutamate, Dopamine and GnRH-II Augment Substantially the Ability of T Cells of Few Head and Neck Cancer Patients to Perform Spontaneous Migration, Chemotactic Migration and Migration towards the Autologous Tumor, and Also Elevate Markedly the Expression of CD3zeta and CD3epsilon TCR-Associated Chains.” Journal of Neural Transmission, vol. 121, no. 8, Aug. 2014, pp. 1007–27. EBSCOhost, https://doi.org/10.1007/s00702-014-1242-y.
APA
Saussez, S., Laumbacher, B., Chantrain, G., Rodriguez, A., Gu, S., Wank, R., & Levite, M. (2014). Towards Neuroimmunotherapy for Cancer: the Neurotransmitters Glutamate, Dopamine and GnRH-II augment substantially the ability of T cells of few Head and Neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains. Journal of Neural Transmission, 121(8), 1007–1027. https://doi.org/10.1007/s00702-014-1242-y
Chicago
Saussez, Sven, Barbara Laumbacher, Gilbert Chantrain, Alexandra Rodriguez, Songhai Gu, Rudolf Wank, and Mia Levite. 2014. “Towards Neuroimmunotherapy for Cancer: The Neurotransmitters Glutamate, Dopamine and GnRH-II Augment Substantially the Ability of T Cells of Few Head and Neck Cancer Patients to Perform Spontaneous Migration, Chemotactic Migration and Migration towards the Autologous Tumor, and Also Elevate Markedly the Expression of CD3zeta and CD3epsilon TCR-Associated Chains.” Journal of Neural Transmission 121 (8): 1007–27. doi:10.1007/s00702-014-1242-y.